Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy

SIMPLE SUMMARY: We aimed to develop an antibody panel and data analysis algorithm for multicolor flow cytometry (MFC), which is a reliable method for minimal residual disease (MRD) detection in patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) treated with CD19-directed therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Mikhailova, Ekaterina, Illarionova, Olga, Komkov, Alexander, Zerkalenkova, Elena, Mamedov, Ilgar, Shelikhova, Larisa, Olshanskaya, Yulia, Miakova, Natalia, Novichkova, Galina, Karachunskiy, Alexander, Maschan, Michael, Popov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658935/
https://www.ncbi.nlm.nih.gov/pubmed/36358863
http://dx.doi.org/10.3390/cancers14215445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658935/
https://www.ncbi.nlm.nih.gov/pubmed/36358863
http://dx.doi.org/10.3390/cancers14215445

Ejemplares similares